Combining Latency Reversing Agents to Address the HIV Reservoir

NCT07384624 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HIV (Human Immunodeficiency Virus)
HIV -1 Infection

Interventions

DRUG: Pyrimethamine (PYR)
DRUG: Lenalidomide
DRUG: Topiramate (drug)

Sponsor

Erasmus Medical Center